[Myelopoietic effect of medroxyprogesterone acetate at high parenteral doses in the cancer patient].
D000970:Antineoplastic Agents / Q000008:administration & dosage; D001853:Bone Marrow / Q000187:drug effects; D005260:Female; D006410:Hematopoiesis / Q000187:drug effects*; D006801:Humans; D008297:Male; D008525:Medroxyprogesterone / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D008875:Middle Aged; D009369:Neoplasms / Q000097:blood / Q000188:drug therapy*; D011897:Random Allocation
D000970:Antineoplastic Agents; D008525:Medroxyprogesterone
Efecto mielopoyético del acetato de medroxiprogesterona (MAP)--altas dosis parenterales--en el paciente neoplásico.